Asymmetric Dimethylarginine Is a Well Established Mediating Risk Factor for Cardiovascular Morbidity and Mortality—Should Patients with Elevated Levels Be Supplemented with Citrulline?

The arginine metabolite asymmetric dimethylarginine (ADMA) is a competitive inhibitor and uncoupler of endothelial nitric oxide synthase (eNOS), an enzyme that acts in multifarious ways to promote cardiovascular health. This phenomenon likely explains, at least in part, why elevated ADMA has been es...

Descripción completa

Detalles Bibliográficos
Autor principal: McCarty, Mark F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5041041/
https://www.ncbi.nlm.nih.gov/pubmed/27417628
http://dx.doi.org/10.3390/healthcare4030040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5041041/
https://www.ncbi.nlm.nih.gov/pubmed/27417628
http://dx.doi.org/10.3390/healthcare4030040

Ejemplares similares